| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
plasminogen activator, urokinase receptor | 0.536 | 0.731 | 5.3E-03 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2012 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.310 | None | 1.000 | 7 | 0 | 2003 | 2014 | ||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2012 | ||||||||
|
chitinase 3 like 1 | 0.419 | 0.885 | 1.1E-05 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2010 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 1992 | 2002 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
phenotype | 0.300 | None | 1.000 | 6 | 0 | 2000 | 2012 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.300 | None | 1.000 | 5 | 0 | 2013 | 2016 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
phenotype | 0.300 | None | 1.000 | 5 | 0 | 2005 | 2016 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.300 | None | 1.000 | 4 | 0 | 2011 | 2014 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
phenotype | 0.300 | None | 1.000 | 4 | 0 | 2008 | 2013 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2010 | 2015 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2012 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2015 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2009 | 2013 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2015 | 2017 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2018 | ||||||||
|
protein tyrosine kinase 2 | 0.497 | 0.808 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2015 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2016 | 2017 | ||||||||
|
snail family transcriptional repressor 1 | 0.474 | 0.808 | 0.22 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2012 | 2013 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1998 | 2005 | ||||||||
|
SRC proto-oncogene, non-receptor tyrosine kinase | 0.467 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2009 | 2011 | ||||||||
|
cystatin B | 0.530 | 0.692 | 6.6E-03 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2012 | ||||||||
|
myosin light chain kinase | 0.510 | 0.846 | 9.2E-12 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1999 | 2003 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2015 |